# Mastercard Inc: financial statements, quarterly

MA · NYSE · CIK 1141391 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/ma.md) · [Financials](/companies/ma/financials.md) · [Filings](/companies/ma/filings.md) · [Insiders](/companies/ma/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/ma/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [6,533](/filings/0001141391-24-000202.md) | [6,548 d](/filings/0001141391-26-000013.md) | [6,348](/filings/0001141391-25-000090.md) | [6,961](/filings/0001141391-25-000172.md) | [7,369](/filings/0001141391-25-000193.md) | [7,489 d](/filings/0001141391-26-000013.md) | [7,250](/filings/0001141391-26-000031.md) | [8,133](/filings/0001141391-26-000083.md) | [8,602](/filings/0001141391-25-000193.md) | [8,806 d](/filings/0001141391-26-000013.md) | [8,398](/filings/0001141391-26-000031.md) | [9,277](/filings/0001141391-26-000083.md) |
| Operating income | $m | [3,844](/filings/0001141391-24-000202.md) | [3,372 d](/filings/0001141391-26-000013.md) | [3,604](/filings/0001141391-25-000090.md) | [4,036](/filings/0001141391-25-000172.md) | [4,004](/filings/0001141391-25-000193.md) | [3,938 d](/filings/0001141391-26-000013.md) | [4,149](/filings/0001141391-26-000031.md) | [4,777](/filings/0001141391-26-000083.md) | [5,061](/filings/0001141391-25-000193.md) | [4,910 d](/filings/0001141391-26-000013.md) | [4,907](/filings/0001141391-26-000031.md) | [5,587](/filings/0001141391-26-000083.md) |
| Interest expense | $m | [151](/filings/0001141391-24-000202.md) | [148 d](/filings/0001141391-24-000022.md) | [150](/filings/0001141391-24-000087.md) | [153](/filings/0001141391-24-000161.md) | [159](/filings/0001141391-24-000202.md) | [184 d](/filings/0001141391-26-000013.md) | [182](/filings/0001141391-26-000031.md) | [195](/filings/0001141391-26-000083.md) | [186](/filings/0001141391-25-000193.md) | [159 d](/filings/0001141391-26-000013.md) | [185](/filings/0001141391-26-000031.md) | [218](/filings/0001141391-26-000083.md) |
| Income tax | $m | [563](/filings/0001141391-24-000202.md) | [530 d](/filings/0001141391-26-000013.md) | [547](/filings/0001141391-25-000090.md) | [681](/filings/0001141391-25-000172.md) | [603](/filings/0001141391-25-000193.md) | [549 d](/filings/0001141391-26-000013.md) | [751](/filings/0001141391-26-000031.md) | [971](/filings/0001141391-26-000083.md) | [1,072](/filings/0001141391-25-000193.md) | [816 d](/filings/0001141391-26-000013.md) | [930](/filings/0001141391-26-000031.md) | [1,098](/filings/0001141391-26-000083.md) |
| Net income | $m | [3,198](/filings/0001141391-24-000202.md) | [2,791 d](/filings/0001141391-26-000013.md) | [3,011](/filings/0001141391-25-000090.md) | [3,258](/filings/0001141391-25-000172.md) | [3,263](/filings/0001141391-25-000193.md) | [3,342 d](/filings/0001141391-26-000013.md) | [3,280](/filings/0001141391-26-000031.md) | [3,701](/filings/0001141391-26-000083.md) | [3,927](/filings/0001141391-25-000193.md) | [4,060 d](/filings/0001141391-26-000013.md) | [3,882](/filings/0001141391-26-000031.md) | [4,388](/filings/0001141391-26-000083.md) |
| Diluted EPS | $ per share | [3.39](/filings/0001141391-24-000202.md) | not reported | [3.22](/filings/0001141391-25-000090.md) | [3.50](/filings/0001141391-25-000172.md) | [3.53](/filings/0001141391-25-000193.md) | not reported | [3.59](/filings/0001141391-26-000031.md) | [4.07](/filings/0001141391-26-000083.md) | [4.34](/filings/0001141391-25-000193.md) | not reported | [4.35](/filings/0001141391-26-000031.md) | [4.97](/filings/0001141391-26-000083.md) |
| Basic EPS | $ per share | [3.40](/filings/0001141391-24-000202.md) | not reported | [3.23](/filings/0001141391-25-000090.md) | [3.51](/filings/0001141391-25-000172.md) | [3.54](/filings/0001141391-25-000193.md) | not reported | [3.60](/filings/0001141391-26-000031.md) | [4.08](/filings/0001141391-26-000083.md) | [4.35](/filings/0001141391-25-000193.md) | not reported | [4.35](/filings/0001141391-26-000031.md) | [4.98](/filings/0001141391-26-000083.md) |

- Revenue: us-gaap:Revenues
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:ProfitLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [6.9](/filings/0001141391-23-000157.md) | [8.6](/filings/0001141391-25-000011.md) | [7.3](/filings/0001141391-24-000087.md) | [7.0](/filings/0001141391-24-000161.md) | [11.1](/filings/0001141391-24-000202.md) | [8.4](/filings/0001141391-26-000013.md) | [7.6](/filings/0001141391-25-000090.md) | [9.0](/filings/0001141391-25-000172.md) | [10.3](/filings/0001141391-25-000193.md) | [10.6](/filings/0001141391-26-000083.md) | [7.9](/filings/0001141391-26-000031.md) | [11.3](/filings/0001141391-26-000083.md) |
| Current assets | $bn | [17.0](/filings/0001141391-23-000157.md) | [19.0](/filings/0001141391-25-000011.md) | [18.4](/filings/0001141391-24-000087.md) | [17.8](/filings/0001141391-24-000161.md) | [22.3](/filings/0001141391-24-000202.md) | [19.7](/filings/0001141391-26-000013.md) | [19.8](/filings/0001141391-25-000090.md) | [22.1](/filings/0001141391-25-000172.md) | [23.2](/filings/0001141391-25-000193.md) | [23.6](/filings/0001141391-26-000083.md) | [22.5](/filings/0001141391-26-000031.md) | [26.5](/filings/0001141391-26-000083.md) |
| Total assets | $bn | [39.7](/filings/0001141391-23-000157.md) | [42.4](/filings/0001141391-25-000011.md) | [42.6](/filings/0001141391-24-000087.md) | [42.3](/filings/0001141391-24-000161.md) | [47.2](/filings/0001141391-24-000202.md) | [48.1](/filings/0001141391-26-000013.md) | [48.5](/filings/0001141391-25-000090.md) | [51.4](/filings/0001141391-25-000172.md) | [53.3](/filings/0001141391-25-000193.md) | [54.2](/filings/0001141391-26-000083.md) | [52.4](/filings/0001141391-26-000031.md) | [57.7](/filings/0001141391-26-000083.md) |
| Current liabilities | $bn | [14.5](/filings/0001141391-23-000157.md) | [16.3](/filings/0001141391-25-000011.md) | [16.9](/filings/0001141391-24-000087.md) | [15.6](/filings/0001141391-24-000161.md) | [17.3](/filings/0001141391-24-000202.md) | [19.2](/filings/0001141391-26-000013.md) | [17.8](/filings/0001141391-25-000090.md) | [19.0](/filings/0001141391-25-000172.md) | [20.7](/filings/0001141391-25-000193.md) | [22.8](/filings/0001141391-26-000083.md) | [22.9](/filings/0001141391-26-000031.md) | [25.0](/filings/0001141391-26-000083.md) |
| Total liabilities | $bn | [33.3](/filings/0001141391-23-000157.md) | [35.5](/filings/0001141391-25-000011.md) | [35.3](/filings/0001141391-24-000087.md) | [34.9](/filings/0001141391-24-000161.md) | [39.7](/filings/0001141391-24-000202.md) | [41.6](/filings/0001141391-26-000013.md) | [41.8](/filings/0001141391-25-000090.md) | [43.6](/filings/0001141391-25-000172.md) | [45.4](/filings/0001141391-25-000193.md) | [46.4](/filings/0001141391-26-000083.md) | [45.7](/filings/0001141391-26-000031.md) | [52.1](/filings/0001141391-26-000083.md) |
| Long-term debt | $bn | [14.2](/filings/0001141391-23-000157.md) | [14.3](/filings/0001141391-25-000011.md) | [13.5](/filings/0001141391-24-000087.md) | [14.5](/filings/0001141391-24-000161.md) | [17.6](/filings/0001141391-24-000202.md) | [17.5](/filings/0001141391-26-000013.md) | [18.8](/filings/0001141391-25-000090.md) | [19.0](/filings/0001141391-25-000172.md) | [19.0](/filings/0001141391-25-000193.md) | [18.3](/filings/0001141391-26-000083.md) | [17.2](/filings/0001141391-26-000031.md) | [22.2](/filings/0001141391-26-000083.md) |
| Current portion of debt | $bn | [1.3](/filings/0001141391-23-000157.md) | [1.3](/filings/0001141391-25-000011.md) | [2.1](/filings/0001141391-24-000087.md) | [1.1](/filings/0001141391-24-000161.md) | [0.8](/filings/0001141391-24-000202.md) | [0.8](/filings/0001141391-26-000013.md) | [0.0](/filings/0001141391-25-000090.md) | [0.0](/filings/0001141391-25-000172.md) | [0.0](/filings/0001141391-25-000193.md) | [0.7](/filings/0001141391-26-000083.md) | [1.7](/filings/0001141391-26-000031.md) | [2.5](/filings/0001141391-26-000083.md) |
| Shareholders' equity | $bn | [6.3](/filings/0001141391-23-000157.md) | [6.9](/filings/0001141391-25-000011.md) | [7.2](/filings/0001141391-24-000087.md) | [7.4](/filings/0001141391-24-000161.md) | [7.4](/filings/0001141391-24-000202.md) | [6.5](/filings/0001141391-26-000013.md) | [6.7](/filings/0001141391-25-000090.md) | [7.9](/filings/0001141391-25-000172.md) | [7.9](/filings/0001141391-25-000193.md) | [7.7](/filings/0001141391-26-000083.md) | [6.7](/filings/0001141391-26-000031.md) | [5.6](/filings/0001141391-26-000083.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [3,233 d](/filings/0001141391-24-000202.md) | [4,130 d](/filings/0001141391-26-000013.md) | [1,672](/filings/0001141391-25-000090.md) | [3,138 d](/filings/0001141391-25-000172.md) | [5,136 d](/filings/0001141391-25-000193.md) | [4,834 d](/filings/0001141391-26-000013.md) | [2,380](/filings/0001141391-26-000031.md) | [4,603 d](/filings/0001141391-26-000083.md) | [5,663 d](/filings/0001141391-25-000193.md) | [5,002 d](/filings/0001141391-26-000013.md) | [2,999](/filings/0001141391-26-000031.md) | [3,773 d](/filings/0001141391-26-000083.md) |
| Capital expenditure | $m | [104 d](/filings/0001141391-24-000202.md) | [77.0 d](/filings/0001141391-26-000013.md) | [157](/filings/0001141391-25-000090.md) | [115 d](/filings/0001141391-25-000172.md) | [107 d](/filings/0001141391-25-000193.md) | [95.0 d](/filings/0001141391-26-000013.md) | [159](/filings/0001141391-26-000031.md) | [40.0 d](/filings/0001141391-26-000083.md) | [178 d](/filings/0001141391-25-000193.md) | [112 d](/filings/0001141391-26-000013.md) | [154](/filings/0001141391-26-000031.md) | [291 d](/filings/0001141391-26-000083.md) |
| Dividends paid | $m | [538 d](/filings/0001141391-24-000202.md) | [534 d](/filings/0001141391-26-000013.md) | [616](/filings/0001141391-25-000090.md) | [615 d](/filings/0001141391-25-000172.md) | [611 d](/filings/0001141391-25-000193.md) | [606 d](/filings/0001141391-26-000013.md) | [694](/filings/0001141391-26-000031.md) | [691 d](/filings/0001141391-26-000083.md) | [687 d](/filings/0001141391-25-000193.md) | [684 d](/filings/0001141391-26-000013.md) | [777](/filings/0001141391-26-000031.md) | [771 d](/filings/0001141391-26-000083.md) |
| Share repurchases | $m | [1,906 d](/filings/0001141391-24-000202.md) | [1,832 d](/filings/0001141391-26-000013.md) | [1,992](/filings/0001141391-25-000090.md) | [2,639 d](/filings/0001141391-25-000172.md) | [2,934 d](/filings/0001141391-25-000193.md) | [3,389 d](/filings/0001141391-26-000013.md) | [2,549](/filings/0001141391-26-000031.md) | [2,289 d](/filings/0001141391-26-000083.md) | [3,331 d](/filings/0001141391-25-000193.md) | [3,558 d](/filings/0001141391-26-000013.md) | [4,035](/filings/0001141391-26-000031.md) | [4,898 d](/filings/0001141391-26-000083.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [968](/filings/0001141391-23-000157.md) | [956](/filings/0001141391-24-000087.md) | [949](/filings/0001141391-24-000161.md) | [943](/filings/0001141391-24-000202.md) | [935](/filings/0001141391-25-000090.md) | [930](/filings/0001141391-25-000172.md) | [925](/filings/0001141391-25-000193.md) | [914](/filings/0001141391-26-000031.md) | [909](/filings/0001141391-26-000083.md) | [905](/filings/0001141391-25-000193.md) | [893](/filings/0001141391-26-000031.md) | [883](/filings/0001141391-26-000083.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 122,530,193 at 2010-10-27, from the cover of the [10-Q filed 2010-11-02](/filings/0001193125-10-243917.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:34 ET. No prices; not investment advice.